R56 Program
R56 is a recognized activity code under which applications can be funded at NIH and that will allow Institutes and Centers (ICs) to submit to participating OD Offices nominations for research proposals. The R56 program is a collaborative effort in which offices within the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI) send out a single internal announcement to call for applications and fund applications independently. For fiscal years (FYs) 2014 and 2015, ORWH, the Office of AIDS Research (OAR), and the Office of Behavioral and Social Sciences Research collaborated. In FYs 2016 and 2017, ORWH, OAR, and the Office of Disease Prevention – Office of Dietary Supplements have partnered together.
The objective of the R56 program is to implement a flexible funding opportunity that allows program offices within DPCPSI to partner with NIH ICs to provide funds for meritorious Type 1 or Type 2 research applications (A0, A1) that are highly relevant to the mission of the participating OD Offices and that fall just outside the IC pay line. The R56 program allows a principal investigator (PI) to further develop his or her research proposal for a new, competing renewal, or resubmission application. This funding offers the investigator an opportunity to improve the research proposal significantly so that the submission or resubmission application will succeed in a highly competitive peer review and fiscal environment. In addition, the use of the R56 activity code can potentially enhance research in targeted areas, such as the influence of sex and gender on health and disease.
Projects funded through the R56 program in FY14 and FY15 include:
|
Project Title |
PI |
Issuing IC |
|---|---|---|
|
Mechanisms of Macrophage Activation and Function in Scleroderma |
Patricia A. Pioli |
NIAMS |
|
Imaging data re-analysis for cocaine addiction |
Ze Wang |
NIDA |
|
Cost-Effectiveness and Efficacy of Computerized Therapy for Depression and Drug Use |
Suzette V Glasner-Edwards |
NIDA |
|
A Videoconferencing Tobacco Cessation Research Study (Victory) |
Sun Seog Kim |
NIDA |
|
Community-Clinic Partnership to Promote Physical Activity in South Asian Women |
Namratha Kandula
|
NIDDK |
|
Probiotic Analgesia for Pelvic Pain |
David J. Klumpp |
NIDDK |
|
Toxicokinetics and metabolic disruption actions of the flame retardant mixture FM |
Heather B. Patisaul |
NIEHS |
|
Sex differences in myocardial ischemia/reperfusion injury |
Arthur P. Arnold |
NHLBI |
|
Creatine Monohydrate Supplementation in Methamphetamine-Using Female |
Perry Franklin Renshaw |
NIDA |
|
Corticotropin-Releasing Factor/Serotonergic Interactions |
Rita Valentino |
NIMH |
|
Immune modulation of hypertension |
Kathryn L. Sandberg |
NHLBI |
|
Impact of Prenatal Hypoxia on Mitochondrial Function of Offspring Hearts |
Loren P. Thompson
|
NHLBI |
|
The interaction of varenicline, ethanol, and CNS development |
Dustin W. DuBois |
NIAAA |
|
Stress and Decision-Making in Older Persons: Toward a Neurobehavioral Phenotype |
Natalie L. Denburg |
NIA |
|
Circulating MicroRNAs and TLR8 Activation in Chronic Pain |
Asma Khan |
NIDCR |
|
The Female Urinary Microbiome and Urinary Incontinence |
Linda Brubaker |
NIDDK |
|
Improving Heart Transplant Allocation to Reduce High Waitlist Mortality in Women |
Eileen Michelle Hsich |
NHLBI |
|
Neurodevelopmental Features of Sexual Dimorphism in Pediatric Psychopathology |
Manpreet K Singh |
NIMH |
|
Altering the physical microenvironment and enhancing lipid availability for in vitro follicle and oocyte development |
Nucharin Songsasen |
OD |
|
Mitochondrial function and insulin sensitivity in African American women |
James DeLany |
NIDDK |
|
Estradiol and Hippocampal Development |
Margaret M. McCarthy |
NINDS |